Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

300 Results

Guidelines and Advice

Radiopharmaceuticals in the Palliation of Painful Bone Metastases

Status: Archived
ID: 14-1

Jan 2015

Guidelines and Advice

Sunitinib Malate for Gastrointestinal Stromal Tumour (GIST) in Imatinib Mesylate Resistant Patients

Status: Archived
ID: 11-8
Version: 2

Oct 2015

Guidelines and Advice

Implementation Strategy for Radiation Therapy Safety Straps

Status: Current
ID: GL-C50-22

Oct 2015

Guidelines and Advice

Recommendation Report: Entry and Transfer of Care Criteria for Lung Diagnostic Assessment Programs (DAPs) in Ontario

Status: Education and Information
ID: GL-C50-23-V1
Version: 2

Dec 2015

Drug Safety & Advice

Reference List for Appendix 2 - Extravasation Potential of Various Chemotherapy/Supportive Agents

Jul 2015

Statistical Reports

Cancer in the Métis People of Ontario: Risk Factors and Screening Behaviours

Jul 2015

Statistical Reports

Cancer Risk Factors in Ontario: Healthy Weights, Healthy Eating and Active Living

Mar 2015

Guidelines and Advice

Cancer Care Ontario’s Focus on Take-Home Cancer Drugs and Community Practice

Status: Current
ID: GL-C50-17

Jan 2015

Guidelines and Advice

Clinical Verification of Cancer Drug Prescriptions Checklist: Cancer Centres and Specialty Pharmacies

Status: Current
ID: GL-C50-18

Jan 2015

Guidelines and Advice

Recommended Criteria of a Pre-printed Order (PPO): Oral Chemotherapy Take-home Prescriptions

Status: Current
ID: GL-C50-21

Jul 2015

Guidelines and Advice

Person-Centred Care Guideline

Status: Current
ID: GL-C50-20

May 2015

Drug

vinorelbine

Other Name(s): Navelbine®

Quick Link(s):

Drug Monograph, Patient Info Sheet

Apr 2023

Pages